ImportantUpdates
Biocon Malaysia received EMA approval for its new insulin fill-finish unit.
Biocon LimitedBIOCON · Filed with the exchange
This expands manufacturing capacity for Semglee® (insulin glargine), enabling European market supplies to commence in Q2FY27.
No comments yet. Be the first.